Inhibiting BCAA metabolism (such as using BCAT1 inhibitors) can reverse resistance and enhance cancer cells’ sensitivity to chemotherapy, targeted therapy, and immunotherapy (Table 2). This evidence concerns the gene ARID4B and cancer.